Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11) - Université de Rennes Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2015

Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11)

F. Foley
  • Function : Author
I. -K. Penner
  • Function : Author
M. S. Freedman
  • Function : Author
X. Montalban
  • Function : Author
H. -P. Hartung
  • Function : Author
B. Hemmer
  • Function : Author
E. J. Fox
  • Function : Author
R. Koelbach
  • Function : Author
D. Pleimes
  • Function : Author
C. Pohl
  • Function : Author
R. Sandbrink
  • Function : Author
G. Suarez
  • Function : Author
E. -M. Wicklein
  • Function : Author

Abstract

no abstract
No file

Dates and versions

hal-01259395 , version 1 (20-01-2016)

Identifiers

  • HAL Id : hal-01259395 , version 1

Cite

F. Foley, I. -K. Penner, Gilles Edan, M. S. Freedman, X. Montalban, et al.. Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11). Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.249--251. ⟨hal-01259395⟩
29 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More